Dana-Farber Cancer Institute

49.1k papers and 3.3M indexed citations i.

About

In recent decades, authors affiliated with Dana-Farber Cancer Institute have published 49.1k papers, which have received a total of 3.3M indexed citations. Scholars at this organization have produced 16.2k papers in Oncology, 15.6k papers in Molecular Biology and 9.4k papers in Pulmonary and Respiratory Medicine on the topics of Cancer Genomics and Diagnostics (2.6k papers), Immune Cell Function and Interaction (2.5k papers) and Cancer Immunotherapy and Biomarkers (2.4k papers). Their work is cited by papers focused on Molecular Biology (1.5M citations), Oncology (930.1k citations) and Immunology (541.9k citations). Authors at Dana-Farber Cancer Institute collaborate with scholars in United States, Canada and United Kingdom and have published in prestigious journals including Nature, Science and Cell. Some of Dana-Farber Cancer Institute's most productive authors include Bruce M. Spiegelman, Michael I. Love, Wolfgang Huber, Simon Anders, Stuart H. Orkin, Kenneth C. Anderson, Gordon J. Freeman, Matthew G. Vander Heiden, Todd R. Golub and William G. Kaelin.

In The Last Decade

Fields of papers published by authors at Dana-Farber Cancer Institute

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Dana-Farber Cancer Institute at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Dana-Farber Cancer Institute at the time of their publication.

Countries citing scholars working at Dana-Farber Cancer Institute

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Dana-Farber Cancer Institute. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Dana-Farber Cancer Institute with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana-Farber Cancer Institute more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025